Literature DB >> 16298215

Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors.

Goodarz Danaei1, Stephen Vander Hoorn, Alan D Lopez, Christopher J L Murray, Majid Ezzati.   

Abstract

INTRODUCTION: With respect to reducing mortality, advances in cancer treatment have not been as effective as those for other chronic diseases; effective screening methods are available for only a few cancers. Primary prevention through lifestyle and environmental interventions remains the main way to reduce the burden of cancers. In this report, we estimate mortality from 12 types of cancer attributable to nine risk factors in seven World Bank regions for 2001.
METHODS: We analysed data from the Comparative Risk Assessment project and from new sources to assess exposure to risk factors and relative risk by age, sex, and region. We applied population attributable fractions for individual and multiple risk factors to site-specific cancer mortality from WHO.
FINDINGS: Of the 7 million deaths from cancer worldwide in 2001, an estimated 2.43 million (35%) were attributable to nine potentially modifiable risk factors. Of these, 0.76 million deaths were in high-income countries and 1.67 million in low-and-middle-income nations. Among low-and-middle-income regions, Europe and Central Asia had the highest proportion (39%) of deaths from cancer attributable to the risk factors studied. 1.6 million of the deaths attributable to these risk factors were in men and 0.83 million in women. Smoking, alcohol use, and low fruit and vegetable intake were the leading risk factors for death from cancer worldwide and in low-and-middle-income countries. In high-income countries, smoking, alcohol use, and overweight and obesity were the most important causes of cancer. Sexual transmission of human papilloma virus is a leading risk factor for cervical cancer in women in low-and-middle-income countries.
INTERPRETATION: Reduction of exposure to key behavioural and environmental risk factors would prevent a substantial proportion of deaths from cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16298215     DOI: 10.1016/S0140-6736(05)67725-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  339 in total

1.  A theory-based intervention to improve breast cancer awareness and screening in Jamaica.

Authors:  Chidinma P Anakwenze; Evelyn Coronado-Interis; Maung Aung; Pauline E Jolly
Journal:  Prev Sci       Date:  2015-05

2.  The global cancer epidemic: opportunities for Canada in low- and middle-income countries.

Authors:  Ophira M Ginsburg; Timothy P Hanna; Theodore Vandenberg; Anil A Joy; Mark Clemons; Melaku Game; Ronald Maccormick; Lorraine M Elit; Barry Rosen; Yasmin Rahim; William Geddie; Simon B Sutcliffe; Mary Gospodarowicz
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

3.  Communicating evidence-based information on cancer prevention to state-level policy makers.

Authors:  Ross C Brownson; Elizabeth A Dodson; Katherine A Stamatakis; Christopher M Casey; Michael B Elliott; Douglas A Luke; Christopher G Wintrode; Matthew W Kreuter
Journal:  J Natl Cancer Inst       Date:  2011-01-06       Impact factor: 13.506

4.  Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study.

Authors:  Hla-Hla Thein; Edwin Khoo; Michael A Campitelli; Ahmad Zaheen; Qilong Yi; Prithwish De; C C Earle
Journal:  CMAJ Open       Date:  2015-04-02

5.  Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, China.

Authors:  Xiaoxiao Wan; Xian Li; Junyan Yang; Wei Lv; Qiming Wang; Ying Chen; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 6.  Pollutional haze as a potential cause of lung cancer.

Authors:  Xuefei Shi; Hongbing Liu; Yong Song
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 7.  A preliminary benefit-risk assessment of varenicline in smoking cessation.

Authors:  Kate Cahill; Lindsay Stead; Tim Lancaster
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer.

Authors:  Giovanni De Manzoni; Gian Luca Baiocchi; Massimo Framarini; Maurizio De Giuli; Domenico D'Ugo; Alberto Marchet; Donato Nitti; Daniele Marrelli; Paolo Morgagni; Andrea Rinnovati; Riccardo Rosati; Franco Roviello; Rosaldo Allieta; Stefano Berti; Umberto Bracale; Patrizio Capelli; Angelo Cavicchi; Natale Di Martino; Annibale Donini; Angelo Filippini; Gianfranco Francioni; Marco Frascio; Alfredo Garofalo; Stefano Maria Giulini; Giovanni Battista Grassi; Paolo Innocenti; Antonio Martino; Gualtiero Mazzocconi; Lorenzo Mazzola; Severino Montemurro; Nicola Palasciano; Gianni Pantuso; Heinrich Pernthaler; Roberto Petri; Diego Piazza; Rosario Sacco; Giovanni Sgroi; Carlo Staudacher; Michele Testa; Carlo Vallicelli; Nereo Vettoretto; Costantino Zingaretti; Lorenzo Capussotti; Mario Morino; Giorgio Maria Verdecchia
Journal:  Updates Surg       Date:  2014-03

9.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

10.  Depressive Symptoms and Tobacco Use: Does Religious Orientation Play a Protective Role?

Authors:  Stacy C Parenteau
Journal:  J Relig Health       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.